<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03427840</url>
  </required_header>
  <id_info>
    <org_study_id>U1111-1208-8608</org_study_id>
    <nct_id>NCT03427840</nct_id>
  </id_info>
  <brief_title>Superior Hypogastric Plexus Blockade in Laparoscopic Hysterectomy</brief_title>
  <official_title>Efficacy of Intraoperative Superior Hypogastric Plexus Blockade for Postoperative Pain in Laparoscopic Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Derince Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Derince Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary indication for superior hypogastric plexus (SHP) block is visceral pelvic pain,
      most commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate.
      Per-cutaneous SHP blocks should be done under guidance of ultrasonography, fluoroscopy,
      magnetic resonance or computed tomography. During minimally invasive laparoscopic surgery,
      percutaneous technique can be done under the guidance of cameras.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic surgeries have many advantages over open surgeries. Laparoscopic procedures are
      mostly preferred for surgical treatment of gynecologic diseases, because of best cosmetically
      results, less perioperative complications, early recovery, and less postoperative pain.

      There are many undesirable effects of systemic reactions to the pain. Accordingly,
      multi-modal analgesic approach (including nerve blocks) for postoperative acute pain can
      decrease the side effects of the drugs (especially opioids) significantly.

      The primary indication for superior hypogastric plexus (SHP) block is visceral pelvic pain,
      most commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate.
      Per-cutaneous SHP blocks should be done under guidance of ultrasonography, fluoroscopy,
      magnetic resonance or computed tomography. During minimally invasive laparoscopic surgery,
      per-cutaneous technique can be done under the guidance of cameras.

      SHP block has been performed by anesthetists or surgeons in Kocaeli Derince Training and
      Research Hospital regularly since they have discovered the advantages of this block
      technique. SHP can be useful to decrease postoperative pain scores and opioid or NSAID
      consumption significantly.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 18, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain scores (PACU)</measure>
    <time_frame>1 hour (postoperatively)</time_frame>
    <description>Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative opioid/NSAID consumption (PACU)</measure>
    <time_frame>1 hour (postoperatively)</time_frame>
    <description>nonsteroid antiinflammatory drugs (NSAID) or opioid drugs that are applied to patients will be noted down.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>rescue analgesic time</measure>
    <time_frame>48 hours (first analgesic demand time will be noted down)</time_frame>
    <description>Time to first analgesic demand at gynecology ward (after transfer from PACU to gynecology ward)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative pain scores (ward)</measure>
    <time_frame>48 hours (postoperatively)</time_frame>
    <description>Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative opioid/NSAID consumption (ward)</measure>
    <time_frame>48 hours (total)</time_frame>
    <description>NSAID or opioid drugs that are applied to patients will be noted down. Target VAS score for NSAID is &gt;4; if there is no response to NSAID and pain is worsening opioid drugs will be applied</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative hemodynamics</measure>
    <time_frame>from SHP block to the end of the surgery (approximately 15 min)</time_frame>
    <description>(If the patient is received a SHP block intraoperatively) post-block hemodynamical parametres will be noted down</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay</measure>
    <time_frame>3-5 days (expected)</time_frame>
    <description>length of hospital stay time will be noted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications due to SHP block</measure>
    <time_frame>3-5 days (from surgery to discharge from the hospital)</time_frame>
    <description>intra/postoperative complications will be noted. (ie: intra-vascular local anesthetic injection, vascular puncture, hemodynamical changes after injection,.. )</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Superior Hypogastric Plexus Block</condition>
  <condition>Hysterectomy</condition>
  <condition>Minimally Invasive Surgery</condition>
  <condition>Laparoscopy</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Gynecologic Disease</condition>
  <arm_group>
    <arm_group_label>Hypo</arm_group_label>
    <description>The participants with a superior hypogastric block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NoHypo</arm_group_label>
    <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retroperitone is opened intraoperatively by the surgeon)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Procedure/Surgery: superior hypogastric block</intervention_name>
    <description>superior hypogastric blockade during surgery</description>
    <arm_group_label>Hypo</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients who are scheduled for elective laparoscopic hysterectomy under general
        anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I - II

          -  Elective laparoscopic hysterectomy

        Exclusion Criteria:

          -  ASA III

          -  Different kind of surgery

          -  Known allergy to local anesthetic drugs

          -  Different analgesia protocol (ie: epidural, TAP block,..)

          -  Refusal of the patient
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>patients who are scheduled for hysterectomy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hande Aytuluk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Derince Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmet Kale, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Derince Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gulfem Basol, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Derince Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hande Aytuluk, MD</last_name>
    <phone>+902623198000</phone>
    <email>handegrbz@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Derince Training and Research Hospital</name>
      <address>
        <city>Kocaeli</city>
        <state>Derince</state>
        <zip>41900</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hande G. Aytuluk, MD</last_name>
      <phone>+90 533 651 56 50</phone>
      <email>handegrbz@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gulfem Basol, MD</last_name>
      <phone>+90 530 140 23 20</phone>
      <email>glfem412010@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Hande G. Aytuluk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gulfem Basol, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ahmet Kale, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Song T, Kim MK, Jung YW, Yun BS, Seong SJ, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG. Minimally invasive compared with open surgery in patients with borderline ovarian tumors. Gynecol Oncol. 2017 Jun;145(3):508-512. doi: 10.1016/j.ygyno.2017.03.019. Epub 2017 Apr 2.</citation>
    <PMID>28381342</PMID>
  </results_reference>
  <results_reference>
    <citation>Lovich-Sapola J, Smith CE, Brandt CP. Postoperative pain control. Surg Clin North Am. 2015 Apr;95(2):301-18. doi: 10.1016/j.suc.2014.10.002. Epub 2015 Jan 24. Review.</citation>
    <PMID>25814108</PMID>
  </results_reference>
  <results_reference>
    <citation>Sindt JE, Brogan SE. Interventional Treatments of Cancer Pain. Anesthesiol Clin. 2016 Jun;34(2):317-39. doi: 10.1016/j.anclin.2016.01.004. Review.</citation>
    <PMID>27208713</PMID>
  </results_reference>
  <results_reference>
    <citation>Erdine S, Yucel A, Celik M, Talu GK. Transdiscal approach for hypogastric plexus block. Reg Anesth Pain Med. 2003 Jul-Aug;28(4):304-8.</citation>
    <PMID>12945023</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>February 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2018</study_first_posted>
  <last_update_submitted>March 17, 2018</last_update_submitted>
  <last_update_submitted_qc>March 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Derince Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Hande G. Aytuluk</investigator_full_name>
    <investigator_title>M.D., Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Superior Hypogastric Plexus Block</keyword>
  <keyword>Hysterectomy</keyword>
  <keyword>Minimally invasive surgery</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>Pain</keyword>
  <keyword>Gynecologic Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Genital Diseases, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The investigators do not prefer to share the study plan and records.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

